Our Blog

MXC Capital Limited – Proposed Cancellation of AIM Admission

MXC (AIM: MXCP), the technology focused adviser and investor, announces that, following a thorough review of the strategic options open to the Company, the Directors have concluded that it is in the best interests of the Company and its Shareholders to seek Shareholder approval for the cancellation of admission of the Ordinary Shares to trading on AIM.

Read More

TechFinancials Inc. – Proposed AIM cancellation

The Company announces that, as a result of the continuing regulatory challenges facing the Company’s traditional systems unit, the Company has taken the decision to make substantial adjustments to its operating structure and cost base while seeking to develop its newer blockchain based businesses.

Read More

Defenx plc – Proposed cancellation of admission to AIM

Defenx PLC (AIM: DFX), the cyber-security software group, announces that it intends to seek shareholder approval to cancel the admission of its ordinary shares of 1.8 pence each in the capital of the Company (“Ordinary Shares”) to trading on the AIM Market of the London Stock Exchange (the “Cancellation”). 

Read More

Albert Technologies Ltd – Proposed Cancellation of trading on AIM

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce positive data from its pharmacokinetic (“PK”) study FM58 of MED2002, the Company’s topical gel for erectile dysfunction (“ED”). MED2002 contains glyceryl trinitrate (“GTN”) as its active ingredient.

Read More

RISK WARNING